The price set by the Swiss drugmaker Novartis may be the world’s highest for a single treatment — prompting renewed debate about how society will pay for gene-therapy breakthroughs.
Published: May 24, 2019 at 02:00AM
from NYT Health https://nyti.ms/2HYjDo2